QInscribe reports AI-enabled workflows cut draft CSR time by 90%.
Draft clinical study reports traditionally take 50-100 hours. QInscribe, a medical writing service, combines generative AI workflows with experienced writers to produce regulatory, scientific and transparency documents. The release reports draft CSRs in about 5 hours, a 90% reduction.
QInscribe is an AI-enabled medical writing service, used by pharma and biotech sponsors to produce draft clinical study reports and regulatory documents faster
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by QInscribe on its own site — read the original case study on biospace.com ↗
Note: Launch press release; customers not named.
Related use cases
- 01Transforming Content Operations for 2x Faster Time to Market
- 02Astellas: Breaking Access Barriers with Veeva Compliant Chat
- 03How Pacira Generated Deep Website Insights to Get Patients on Therapy Faster
- 04Reaching Underserved Communities with Smarter Targeting
- 05Building Agile Territory Strategies to Scale Pre-Commercial Field Teams
- 06How Alfasigma Unified Regulatory Data and Processes for Cross-Functional Alignment